| | | | | |
EDIT Editas Medicine, Inc. Common Stock | €2,2876 | -3,65% | €359,30M | €1,45M | |
BCCQ Bleichroeder Acquisition Corp. III Class A Ordinary Shares | €8,6477 | +0,00% | €358,87M | €18,48K | |
NXG NXG NextGen Infrastructure Income Fund | €47,4755 | -1,81% | €356,99M | €55,98K | |
LAND Gladstone Land Corporation | €8,1798 | +0,32% | €356,95M | €459,13K | |
CYH Community Health Systems, Inc. | €2,5735 | +0,68% | €356,77M | €894,35K | |
CHMG Chemung Financial Corp | €73,8258 | +0,25% | €355,53M | €74,73K | |
CLBR Colombier Acquisition Corp. III | €8,8513 | -0,15% | €355,41M | €83,74K | |
BOC Boston Omaha Corporation | €11,8191 | -0,51% | €354,24M | €220,52K | |
| €30,1239 | +0,42% | €353,84M | €32,93K | |
HFRO Highland Opportunities and Income Fund | €6,0828 | -3,44% | €353,58M | €121,80K | |
| €25,3191 | +1,71% | €353,35M | €81,29K | |
| €4,2112 | -0,21% | €353,07M | €428,21K | |
PRTC PureTech Health plc American Depositary Shares | €15,2504 | +1,03% | €352,87M | €6,04K | |
LRMR Larimar Therapeutics, Inc. Common Stock | €3,4010 | +3,84% | €352,85M | €742,25K | |
RZLT Rezolute, Inc. Common Stock (NV) | €3,6133 | -1,88% | €352,10M | €652,45K | |
